ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Rosiglitazone Market Research Report 2024
Published Date: February 2024
|
Report Code: QYRE-Auto-34H11243
Home | Market Reports | Health| Health Conditions
Global Rosiglitazone Market Research Report 2022
BUY CHAPTERS

Global Rosiglitazone Market Research Report 2024

Code: QYRE-Auto-34H11243
Report
February 2024
Pages:80
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Hengrui Pharma
GSK
Taiji Group
Shengjitang Pharma
Huanghe Pharma
Wanma Pharma
Jingxin Pharma
STADA

Rosiglitazone Market

Rosiglitazone (CAS 122320-73-4), C18H19N3O3S, the formula weight is 357.43, and its form is powder.
The global Rosiglitazone market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Rosiglitazone is more effective in controlling blood sugar and is suitable for the treatment of non-insulin-dependent (type II) diabetes.
This report aims to provide a comprehensive presentation of the global market for Rosiglitazone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rosiglitazone.

Report Scope

The Rosiglitazone market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Rosiglitazone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rosiglitazone manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Rosiglitazone Market Report

Report Metric Details
Report Name Rosiglitazone Market
Segment by Type
  • Rosiglitazone Tablets
  • Rosiglitazone Maleate Tablets
  • Rosiglitazone Hydrochloride Tablets
  • Others
Segment by Application
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Hengrui Pharma, GSK, Taiji Group, Shengjitang Pharma, Huanghe Pharma, Wanma Pharma, Jingxin Pharma, STADA
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Rosiglitazone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Rosiglitazone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Rosiglitazone Market report?

Ans: The main players in the Rosiglitazone Market are Hengrui Pharma, GSK, Taiji Group, Shengjitang Pharma, Huanghe Pharma, Wanma Pharma, Jingxin Pharma, STADA

What are the Application segmentation covered in the Rosiglitazone Market report?

Ans: The Applications covered in the Rosiglitazone Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Rosiglitazone Market report?

Ans: The Types covered in the Rosiglitazone Market report are Rosiglitazone Tablets, Rosiglitazone Maleate Tablets, Rosiglitazone Hydrochloride Tablets, Others

1 Rosiglitazone Market Overview
1.1 Product Overview and Scope of Rosiglitazone
1.2 Rosiglitazone Segment by Type
1.2.1 Global Rosiglitazone Market Value Comparison by Type (2024-2030)
1.2.2 Rosiglitazone Tablets
1.2.3 Rosiglitazone Maleate Tablets
1.2.4 Rosiglitazone Hydrochloride Tablets
1.2.5 Others
1.3 Rosiglitazone Segment by Application
1.3.1 Global Rosiglitazone Market Value by Application: (2024-2030)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Rosiglitazone Market Size Estimates and Forecasts
1.4.1 Global Rosiglitazone Revenue 2019-2030
1.4.2 Global Rosiglitazone Sales 2019-2030
1.4.3 Global Rosiglitazone Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Rosiglitazone Market Competition by Manufacturers
2.1 Global Rosiglitazone Sales Market Share by Manufacturers (2019-2024)
2.2 Global Rosiglitazone Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Rosiglitazone Average Price by Manufacturers (2019-2024)
2.4 Global Rosiglitazone Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Rosiglitazone, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Rosiglitazone, Product Type & Application
2.7 Rosiglitazone Market Competitive Situation and Trends
2.7.1 Rosiglitazone Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Rosiglitazone Players Market Share by Revenue
2.7.3 Global Rosiglitazone Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Rosiglitazone Retrospective Market Scenario by Region
3.1 Global Rosiglitazone Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Rosiglitazone Global Rosiglitazone Sales by Region: 2019-2030
3.2.1 Global Rosiglitazone Sales by Region: 2019-2024
3.2.2 Global Rosiglitazone Sales by Region: 2025-2030
3.3 Global Rosiglitazone Global Rosiglitazone Revenue by Region: 2019-2030
3.3.1 Global Rosiglitazone Revenue by Region: 2019-2024
3.3.2 Global Rosiglitazone Revenue by Region: 2025-2030
3.4 North America Rosiglitazone Market Facts & Figures by Country
3.4.1 North America Rosiglitazone Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Rosiglitazone Sales by Country (2019-2030)
3.4.3 North America Rosiglitazone Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Rosiglitazone Market Facts & Figures by Country
3.5.1 Europe Rosiglitazone Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Rosiglitazone Sales by Country (2019-2030)
3.5.3 Europe Rosiglitazone Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Rosiglitazone Market Facts & Figures by Country
3.6.1 Asia Pacific Rosiglitazone Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Rosiglitazone Sales by Country (2019-2030)
3.6.3 Asia Pacific Rosiglitazone Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Rosiglitazone Market Facts & Figures by Country
3.7.1 Latin America Rosiglitazone Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Rosiglitazone Sales by Country (2019-2030)
3.7.3 Latin America Rosiglitazone Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Rosiglitazone Market Facts & Figures by Country
3.8.1 Middle East and Africa Rosiglitazone Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Rosiglitazone Sales by Country (2019-2030)
3.8.3 Middle East and Africa Rosiglitazone Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Rosiglitazone Sales by Type (2019-2030)
4.1.1 Global Rosiglitazone Sales by Type (2019-2024)
4.1.2 Global Rosiglitazone Sales by Type (2025-2030)
4.1.3 Global Rosiglitazone Sales Market Share by Type (2019-2030)
4.2 Global Rosiglitazone Revenue by Type (2019-2030)
4.2.1 Global Rosiglitazone Revenue by Type (2019-2024)
4.2.2 Global Rosiglitazone Revenue by Type (2025-2030)
4.2.3 Global Rosiglitazone Revenue Market Share by Type (2019-2030)
4.3 Global Rosiglitazone Price by Type (2019-2030)
5 Segment by Application
5.1 Global Rosiglitazone Sales by Application (2019-2030)
5.1.1 Global Rosiglitazone Sales by Application (2019-2024)
5.1.2 Global Rosiglitazone Sales by Application (2025-2030)
5.1.3 Global Rosiglitazone Sales Market Share by Application (2019-2030)
5.2 Global Rosiglitazone Revenue by Application (2019-2030)
5.2.1 Global Rosiglitazone Revenue by Application (2019-2024)
5.2.2 Global Rosiglitazone Revenue by Application (2025-2030)
5.2.3 Global Rosiglitazone Revenue Market Share by Application (2019-2030)
5.3 Global Rosiglitazone Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Hengrui Pharma
6.1.1 Hengrui Pharma Corporation Information
6.1.2 Hengrui Pharma Description and Business Overview
6.1.3 Hengrui Pharma Rosiglitazone Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Hengrui Pharma Rosiglitazone Product Portfolio
6.1.5 Hengrui Pharma Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Rosiglitazone Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GSK Rosiglitazone Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Taiji Group
6.3.1 Taiji Group Corporation Information
6.3.2 Taiji Group Description and Business Overview
6.3.3 Taiji Group Rosiglitazone Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Taiji Group Rosiglitazone Product Portfolio
6.3.5 Taiji Group Recent Developments/Updates
6.4 Shengjitang Pharma
6.4.1 Shengjitang Pharma Corporation Information
6.4.2 Shengjitang Pharma Description and Business Overview
6.4.3 Shengjitang Pharma Rosiglitazone Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Shengjitang Pharma Rosiglitazone Product Portfolio
6.4.5 Shengjitang Pharma Recent Developments/Updates
6.5 Huanghe Pharma
6.5.1 Huanghe Pharma Corporation Information
6.5.2 Huanghe Pharma Description and Business Overview
6.5.3 Huanghe Pharma Rosiglitazone Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Huanghe Pharma Rosiglitazone Product Portfolio
6.5.5 Huanghe Pharma Recent Developments/Updates
6.6 Wanma Pharma
6.6.1 Wanma Pharma Corporation Information
6.6.2 Wanma Pharma Description and Business Overview
6.6.3 Wanma Pharma Rosiglitazone Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Wanma Pharma Rosiglitazone Product Portfolio
6.6.5 Wanma Pharma Recent Developments/Updates
6.7 Jingxin Pharma
6.6.1 Jingxin Pharma Corporation Information
6.6.2 Jingxin Pharma Description and Business Overview
6.6.3 Jingxin Pharma Rosiglitazone Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Jingxin Pharma Rosiglitazone Product Portfolio
6.7.5 Jingxin Pharma Recent Developments/Updates
6.8 STADA
6.8.1 STADA Corporation Information
6.8.2 STADA Description and Business Overview
6.8.3 STADA Rosiglitazone Sales, Revenue and Gross Margin (2019-2024)
6.8.4 STADA Rosiglitazone Product Portfolio
6.8.5 STADA Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Rosiglitazone Industry Chain Analysis
7.2 Rosiglitazone Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Rosiglitazone Production Mode & Process
7.4 Rosiglitazone Sales and Marketing
7.4.1 Rosiglitazone Sales Channels
7.4.2 Rosiglitazone Distributors
7.5 Rosiglitazone Customers
8 Rosiglitazone Market Dynamics
8.1 Rosiglitazone Industry Trends
8.2 Rosiglitazone Market Drivers
8.3 Rosiglitazone Market Challenges
8.4 Rosiglitazone Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Hengrui Pharma
GSK
Taiji Group
Shengjitang Pharma
Huanghe Pharma
Wanma Pharma
Jingxin Pharma
STADA
List of Tables
    Table 1. Global Rosiglitazone Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Rosiglitazone Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Rosiglitazone Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Rosiglitazone Sales (Kg) of Key Manufacturers (2019-2024)
    Table 5. Global Rosiglitazone Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Rosiglitazone Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Rosiglitazone Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Rosiglitazone Average Price (USD/Kg) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Rosiglitazone, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Rosiglitazone, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Rosiglitazone, Product Type & Application
    Table 12. Global Key Manufacturers of Rosiglitazone, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Rosiglitazone by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rosiglitazone as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Rosiglitazone Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Rosiglitazone Sales by Region (2019-2024) & (Kg)
    Table 18. Global Rosiglitazone Sales Market Share by Region (2019-2024)
    Table 19. Global Rosiglitazone Sales by Region (2025-2030) & (Kg)
    Table 20. Global Rosiglitazone Sales Market Share by Region (2025-2030)
    Table 21. Global Rosiglitazone Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Rosiglitazone Revenue Market Share by Region (2019-2024)
    Table 23. Global Rosiglitazone Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Rosiglitazone Revenue Market Share by Region (2025-2030)
    Table 25. North America Rosiglitazone Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Rosiglitazone Sales by Country (2019-2024) & (Kg)
    Table 27. North America Rosiglitazone Sales by Country (2025-2030) & (Kg)
    Table 28. North America Rosiglitazone Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Rosiglitazone Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Rosiglitazone Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Rosiglitazone Sales by Country (2019-2024) & (Kg)
    Table 32. Europe Rosiglitazone Sales by Country (2025-2030) & (Kg)
    Table 33. Europe Rosiglitazone Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Rosiglitazone Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Rosiglitazone Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Rosiglitazone Sales by Region (2019-2024) & (Kg)
    Table 37. Asia Pacific Rosiglitazone Sales by Region (2025-2030) & (Kg)
    Table 38. Asia Pacific Rosiglitazone Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Rosiglitazone Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Rosiglitazone Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Rosiglitazone Sales by Country (2019-2024) & (Kg)
    Table 42. Latin America Rosiglitazone Sales by Country (2025-2030) & (Kg)
    Table 43. Latin America Rosiglitazone Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Rosiglitazone Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Rosiglitazone Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Rosiglitazone Sales by Country (2019-2024) & (Kg)
    Table 47. Middle East & Africa Rosiglitazone Sales by Country (2025-2030) & (Kg)
    Table 48. Middle East & Africa Rosiglitazone Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Rosiglitazone Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Rosiglitazone Sales (Kg) by Type (2019-2024)
    Table 51. Global Rosiglitazone Sales (Kg) by Type (2025-2030)
    Table 52. Global Rosiglitazone Sales Market Share by Type (2019-2024)
    Table 53. Global Rosiglitazone Sales Market Share by Type (2025-2030)
    Table 54. Global Rosiglitazone Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Rosiglitazone Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Rosiglitazone Revenue Market Share by Type (2019-2024)
    Table 57. Global Rosiglitazone Revenue Market Share by Type (2025-2030)
    Table 58. Global Rosiglitazone Price (USD/Kg) by Type (2019-2024)
    Table 59. Global Rosiglitazone Price (USD/Kg) by Type (2025-2030)
    Table 60. Global Rosiglitazone Sales (Kg) by Application (2019-2024)
    Table 61. Global Rosiglitazone Sales (Kg) by Application (2025-2030)
    Table 62. Global Rosiglitazone Sales Market Share by Application (2019-2024)
    Table 63. Global Rosiglitazone Sales Market Share by Application (2025-2030)
    Table 64. Global Rosiglitazone Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Rosiglitazone Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Rosiglitazone Revenue Market Share by Application (2019-2024)
    Table 67. Global Rosiglitazone Revenue Market Share by Application (2025-2030)
    Table 68. Global Rosiglitazone Price (USD/Kg) by Application (2019-2024)
    Table 69. Global Rosiglitazone Price (USD/Kg) by Application (2025-2030)
    Table 70. Hengrui Pharma Corporation Information
    Table 71. Hengrui Pharma Description and Business Overview
    Table 72. Hengrui Pharma Rosiglitazone Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 73. Hengrui Pharma Rosiglitazone Product
    Table 74. Hengrui Pharma Recent Developments/Updates
    Table 75. GSK Corporation Information
    Table 76. GSK Description and Business Overview
    Table 77. GSK Rosiglitazone Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 78. GSK Rosiglitazone Product
    Table 79. GSK Recent Developments/Updates
    Table 80. Taiji Group Corporation Information
    Table 81. Taiji Group Description and Business Overview
    Table 82. Taiji Group Rosiglitazone Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 83. Taiji Group Rosiglitazone Product
    Table 84. Taiji Group Recent Developments/Updates
    Table 85. Shengjitang Pharma Corporation Information
    Table 86. Shengjitang Pharma Description and Business Overview
    Table 87. Shengjitang Pharma Rosiglitazone Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 88. Shengjitang Pharma Rosiglitazone Product
    Table 89. Shengjitang Pharma Recent Developments/Updates
    Table 90. Huanghe Pharma Corporation Information
    Table 91. Huanghe Pharma Description and Business Overview
    Table 92. Huanghe Pharma Rosiglitazone Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 93. Huanghe Pharma Rosiglitazone Product
    Table 94. Huanghe Pharma Recent Developments/Updates
    Table 95. Wanma Pharma Corporation Information
    Table 96. Wanma Pharma Description and Business Overview
    Table 97. Wanma Pharma Rosiglitazone Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 98. Wanma Pharma Rosiglitazone Product
    Table 99. Wanma Pharma Recent Developments/Updates
    Table 100. Jingxin Pharma Corporation Information
    Table 101. Jingxin Pharma Description and Business Overview
    Table 102. Jingxin Pharma Rosiglitazone Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 103. Jingxin Pharma Rosiglitazone Product
    Table 104. Jingxin Pharma Recent Developments/Updates
    Table 105. STADA Corporation Information
    Table 106. STADA Description and Business Overview
    Table 107. STADA Rosiglitazone Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 108. STADA Rosiglitazone Product
    Table 109. STADA Recent Developments/Updates
    Table 110. Key Raw Materials Lists
    Table 111. Raw Materials Key Suppliers Lists
    Table 112. Rosiglitazone Distributors List
    Table 113. Rosiglitazone Customers List
    Table 114. Rosiglitazone Market Trends
    Table 115. Rosiglitazone Market Drivers
    Table 116. Rosiglitazone Market Challenges
    Table 117. Rosiglitazone Market Restraints
    Table 118. Research Programs/Design for This Report
    Table 119. Key Data Information from Secondary Sources
    Table 120. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Rosiglitazone
    Figure 2. Global Rosiglitazone Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Rosiglitazone Market Share by Type in 2023 & 2030
    Figure 4. Rosiglitazone Tablets Product Picture
    Figure 5. Rosiglitazone Maleate Tablets Product Picture
    Figure 6. Rosiglitazone Hydrochloride Tablets Product Picture
    Figure 7. Others Product Picture
    Figure 8. Global Rosiglitazone Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 9. Global Rosiglitazone Market Share by Application in 2023 & 2030
    Figure 10. Hospital Pharmacies
    Figure 11. Retail Pharmacies
    Figure 12. Online Pharmacies
    Figure 13. Global Rosiglitazone Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Rosiglitazone Market Size (2019-2030) & (US$ Million)
    Figure 15. Global Rosiglitazone Sales (2019-2030) & (Kg)
    Figure 16. Global Rosiglitazone Average Price (USD/Kg) & (2019-2030)
    Figure 17. Rosiglitazone Report Years Considered
    Figure 18. Rosiglitazone Sales Share by Manufacturers in 2023
    Figure 19. Global Rosiglitazone Revenue Share by Manufacturers in 2023
    Figure 20. The Global 5 and 10 Largest Rosiglitazone Players: Market Share by Revenue in 2023
    Figure 21. Rosiglitazone Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 22. Global Rosiglitazone Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 23. North America Rosiglitazone Sales Market Share by Country (2019-2030)
    Figure 24. North America Rosiglitazone Revenue Market Share by Country (2019-2030)
    Figure 25. U.S. Rosiglitazone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 26. Canada Rosiglitazone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 27. Europe Rosiglitazone Sales Market Share by Country (2019-2030)
    Figure 28. Europe Rosiglitazone Revenue Market Share by Country (2019-2030)
    Figure 29. Germany Rosiglitazone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. France Rosiglitazone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. U.K. Rosiglitazone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. Italy Rosiglitazone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. Russia Rosiglitazone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. Asia Pacific Rosiglitazone Sales Market Share by Region (2019-2030)
    Figure 35. Asia Pacific Rosiglitazone Revenue Market Share by Region (2019-2030)
    Figure 36. China Rosiglitazone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. Japan Rosiglitazone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. South Korea Rosiglitazone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. India Rosiglitazone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Australia Rosiglitazone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Taiwan Rosiglitazone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Indonesia Rosiglitazone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Thailand Rosiglitazone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Malaysia Rosiglitazone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Philippines Rosiglitazone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. Latin America Rosiglitazone Sales Market Share by Country (2019-2030)
    Figure 47. Latin America Rosiglitazone Revenue Market Share by Country (2019-2030)
    Figure 48. Mexico Rosiglitazone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Brazil Rosiglitazone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 50. Argentina Rosiglitazone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 51. Middle East & Africa Rosiglitazone Sales Market Share by Country (2019-2030)
    Figure 52. Middle East & Africa Rosiglitazone Revenue Market Share by Country (2019-2030)
    Figure 53. Turkey Rosiglitazone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. Saudi Arabia Rosiglitazone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 55. U.A.E Rosiglitazone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 56. Global Sales Market Share of Rosiglitazone by Type (2019-2030)
    Figure 57. Global Revenue Market Share of Rosiglitazone by Type (2019-2030)
    Figure 58. Global Rosiglitazone Price (USD/Kg) by Type (2019-2030)
    Figure 59. Global Sales Market Share of Rosiglitazone by Application (2019-2030)
    Figure 60. Global Revenue Market Share of Rosiglitazone by Application (2019-2030)
    Figure 61. Global Rosiglitazone Price (USD/Kg) by Application (2019-2030)
    Figure 62. Rosiglitazone Value Chain
    Figure 63. Rosiglitazone Production Process
    Figure 64. Channels of Distribution (Direct Vs Distribution)
    Figure 65. Distributors Profiles
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Pulmonary Exerciser - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-20C16992
Thu May 02 00:00:00 UTC 2024

Add to Cart

Medical Nasal Stent - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-2P14533
Thu May 02 00:00:00 UTC 2024

Add to Cart

Pediatric Ventricular Assist Device - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-37H14530
Thu May 02 00:00:00 UTC 2024

Add to Cart

Synthetic Fiber Vascular Prosthesis - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-38F13932
Thu May 02 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions